Clinical Study of QSOX1 as a Biomarker for Colon Cancer

Qianfoshan Hospital

Status: Not yet enrolling

Conditions: Colon Cancer

Treatments: Diagnostic Test: Diagnosis of colon cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05827471

QianfoshanHwyq20230305

Details and patient eligibility

About

The goal of this observational study is to determine whether the secreted protein QSOX1 can be used as a molecular marker for early rapid diagnosis and accurate treatment of colon cancer.

Full description

The project mainly selects the tumor group represented by colon cancer and the corresponding healthy people as the control group, with about 100 cases in each of the two groups. Mainly collect blood and tumor tissue samples of patients, detect the expression of QSOX1 in the above samples, and explore the role in the diagnosis and prognosis evaluation of colon cancer.

Enrollment: 400 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Colon cancer was confirmed by colonoscopic pathology.
• No local or systemic treatment was performed before operation.
• Complete clinical data.

Exclusion criteria

• Combined with benign diseases of colon, such as ulcerative colitis, colon adenoma and colon polyp.
• Other tumors other than colon cancer.

Trial design

400 participants in 2 patient groups

Tumor group

Description:

First diagnosis of colon cancer.

Treatment:

Diagnostic Test: Diagnosis of colon cancer

Control group

Description:

Healthy people.

Treatment:

Diagnostic Test: Diagnosis of colon cancer